FDA Adverse Event Injury Summary report: N

UNK MAMMARY IMPLANT

MDR report key: 22913136 · Received August 28, 2025

Report

Report Number
9617229-2025-14707
Event Type
Injury
Date Received
August 28, 2025
Date of Event
July 21, 2025
Report Date
August 28, 2025
Manufacturer
ALLERGAN (COSTA RICA)
Product Code
FWM
PMA / PMN Number
P990074
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
VA, US
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

CITATION: XU, P.; KOURENTZI, K.; WILLSON, R.; HU, H.; DEVA, A.; CAMPBELL, C.; KADIN, M. LATERAL FLOW ASSAY TO DETECT CARBONIC ANHYDRASE IX IN SEROMAS OF BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA. CANCERS 2025, 17, 2405. HTTPS://DOI.ORG/10.3390/CANCERS17142405. THE EVENTS OF SEROMA-LATE AND LYMPHOMA-ALCL-SUSPECTED ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS. FURTHER INFORMATION FROM THE REPORTER REGARDING EVENT, PRODUCT, OR PATIENT DETAILS HAS BEEN REQUESTED. NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME. THE REASON FOR REOPERATION: SEROMA-LATE, LYMPHOMA-ALCL-SUSPECTED. ADDITIONAL CONTACT INFORMATION: (B)(6).

Description of Event or Problem · 0

THROUGH JOURNAL ARTICLE TITLED ¿LATERAL FLOW ASSAY TO DETECT CARBONIC ANHYDRASE IX IN SEROMAS OF BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA¿ HEALTHCARE PROFESSIONAL REPORTED MALIGNANT SEROMAS AND DIAGNOSIS OF BIA-ALCL. THE SAMPLING REPRESENTS 14 PATIENTS WITH SOME TYPE OF UNKNOWN ALLERGAN DEVICE. THE ORIGINAL TESTING RESULTS FOR BIA-ALCL WERE NOT PROVIDED. HOWEVER, HISTOPATHOLOGICAL MARKER OF CD30+ WAS PRESENT FOR SAMPLES DURING CONDUCTION OF THE ELISA METHOD. ALK- MARKER WAS TESTED FOR OR PROVIDED WITH SAMPLING. THE DEVICES WERE EXPLANTED. THE AFFECTED SIDE(S) ARE UNKNOWN.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2742540 UNK MAMMARY IMPLANT PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE FWM ALLERGAN (COSTA RICA) NI

Patients

Seq Age Sex Outcome Treatment
1 NA Female Life Threatening| R